Drugs / VC-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04678557 | Jun 2019 → Nov 2021 | type 1 diabetes mellitus | ViaCyte | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VC-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04678557 ↗ |
| Action | Restore | “cell replacement therapy intended to provide a functional cure” NCT04678557 ↗ |
| Modality | Cell therapy | “cell replacement therapy intended to provide a functional cure” NCT04678557 ↗ |